Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STX-478 in Advanced Solid Tumors and Breast Cancer
NCT05768139Phase 2Recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2023
- Primary completion
- Jul 2030
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of tersolisib in solid tumor, breast cancer, sponsored by Eli Lilly and Company. Started Apr 2023; status: recruiting.
02
Drugs
tersolisib
03
Conditions
solid tumorbreast cancer
Beyond the preview
Go deeper on NCT05768139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05768139.